Sei Investments Co. Sells 20,315 Shares of Evolent Health, Inc. (NYSE:EVH)

Sei Investments Co. reduced its stake in shares of Evolent Health, Inc. (NYSE:EVH) by 18.6% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 89,054 shares of the technology company’s stock after selling 20,315 shares during the period. Sei Investments Co. owned 0.08% of Evolent Health worth $1,703,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. increased its stake in shares of Evolent Health by 0.9% in the first quarter. Vanguard Group Inc. now owns 10,915,070 shares of the technology company’s stock worth $357,905,000 after purchasing an additional 93,739 shares during the period. Wellington Management Group LLP increased its stake in shares of Evolent Health by 96.1% in the fourth quarter. Wellington Management Group LLP now owns 8,313,157 shares of the technology company’s stock worth $274,584,000 after purchasing an additional 4,073,959 shares during the period. RA Capital Management L.P. increased its stake in shares of Evolent Health by 125.0% in the first quarter. RA Capital Management L.P. now owns 5,736,132 shares of the technology company’s stock worth $188,088,000 after purchasing an additional 3,187,000 shares during the period. William Blair Investment Management LLC increased its stake in shares of Evolent Health by 35.2% in the second quarter. William Blair Investment Management LLC now owns 5,026,043 shares of the technology company’s stock worth $96,098,000 after purchasing an additional 1,308,376 shares during the period. Finally, Point72 Asset Management L.P. increased its stake in shares of Evolent Health by 81.3% in the fourth quarter. Point72 Asset Management L.P. now owns 2,675,000 shares of the technology company’s stock worth $88,355,000 after purchasing an additional 1,199,400 shares during the period.

Insider Buying and Selling at Evolent Health

In other news, CEO Seth Blackley sold 187,904 shares of the business’s stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $30.00, for a total value of $5,637,120.00. Following the transaction, the chief executive officer now directly owns 411,924 shares of the company’s stock, valued at $12,357,720. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, President Daniel Joseph Mccarthy sold 23,693 shares of the business’s stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $30.89, for a total value of $731,876.77. Following the transaction, the president now directly owns 198,809 shares of the company’s stock, valued at $6,141,210.01. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Seth Blackley sold 187,904 shares of the business’s stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $30.00, for a total value of $5,637,120.00. Following the completion of the transaction, the chief executive officer now directly owns 411,924 shares in the company, valued at $12,357,720. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 307,291 shares of company stock valued at $9,290,385. 1.60% of the stock is currently owned by corporate insiders.

Evolent Health Stock Up 0.7 %

NYSE EVH opened at $26.34 on Friday. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 0.57. The stock’s 50 day moving average is $28.08 and its two-hundred day moving average is $26.07. The company has a market capitalization of $3.06 billion, a price-to-earnings ratio of -21.07 and a beta of 1.56. Evolent Health, Inc. has a 1-year low of $17.98 and a 1-year high of $35.00.

Evolent Health (NYSE:EVH) last released its quarterly earnings data on Thursday, August 8th. The technology company reported $0.30 earnings per share for the quarter, beating analysts’ consensus estimates of $0.21 by $0.09. The company had revenue of $647.10 million for the quarter, compared to the consensus estimate of $636.46 million. Evolent Health had a positive return on equity of 8.47% and a negative net margin of 3.16%. The company’s quarterly revenue was up 37.9% on a year-over-year basis. During the same period in the previous year, the business earned $0.06 earnings per share. Equities analysts forecast that Evolent Health, Inc. will post 0.86 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the company. Royal Bank of Canada reiterated an “outperform” rating and issued a $42.00 price objective on shares of Evolent Health in a research note on Monday, August 26th. Stephens reiterated an “overweight” rating and issued a $42.00 price objective on shares of Evolent Health in a research note on Tuesday, July 30th. Truist Financial restated a “buy” rating and set a $33.00 price target on shares of Evolent Health in a research note on Tuesday, August 27th. JMP Securities lowered their price target on Evolent Health from $34.00 to $31.00 and set a “market outperform” rating on the stock in a research note on Friday, August 9th. Finally, JPMorgan Chase & Co. boosted their price target on Evolent Health from $36.00 to $45.00 and gave the company an “overweight” rating in a research note on Monday, August 19th. One investment analyst has rated the stock with a sell rating and twelve have given a buy rating to the company. According to data from MarketBeat, Evolent Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $40.40.

About Evolent Health

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.